6Bowman S J, Pillemer S, Jonsson R, et al. Revisiting Sjogrenb syndrome in the new millennium:perspectlves on assessment and outcome measures[J]. Rheumatology,2001,40(10) : 1 - 180.
7KLESTOV AC, WEBBJ, LATTD, et al. Tratment of xerostomia: A double-blind trial in 108 patients with sjogren's syndrome[ J ]. Oral Med, 1981,51 (6) :594 -599.
8Weseott WB, Mira JC, Stareke EN, et al. Alterrations in whole saliva flow rate induced by fractloned radiotherapy [J]. A JR Am J Roentgenol, 1978,130 : 145 - 149.
9Leslie MD, Dische S. The. curly changes in salivary gland function during and after rsdiotherapy given for head and neck cancer[J]. Radiother Oncol, 1994,30:26 - 32.
10Johnson JT,Ferretti GA ,Nethery WJ. Orel pilocerpin for post -inadiation xerostomia in patients with head and neck cancer[J]. N Engl J Med, 1993,329 (6) :390 - 395.
